Product Information
ESCITALOPRAM 5 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.0416 per EA under NDC 68001059100. Its NADAC has been published 138 times since Feb 14, 2024.
FDA first approved this application on Aug 28, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001059100
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
Generic (ANDA)
FDA Application
ANDA078032FDA Approved
8/28/2015
TE Code
AB
On Market Since
12/18/2023
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM 5 MG TABLET has been published 138 times since Feb 14, 2024, and over the history we have for it it has declined 16.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0416 per EA |
|---|---|
| All-time high | $0.0501 (Apr 10, 2024) |
| All-time low | $0.0328 (Nov 20, 2024) |
| 52-week high | $0.0439 |
| 52-week low | $0.0412 |
| Median price | $0.0423 |
| Average price | $0.0428 |
| Largest weekly change | -27.3% (Nov 20, 2024) |
| Weeks tracked | 138 |
| Tracking since | Feb 14, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Escitalopram market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ESCITALOPRAM 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 5 MG TABLET, manufactured by BluePoint Laboratories, is $0.0416 per EA (NDC 68001059100), effective Sep 30, 2026.
How has the price of ESCITALOPRAM 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM 5 MG TABLET has declined 16.8%. It has been tracked across 138 weekly CMS publications since Feb 14, 2024.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 5 MG TABLET?
Since Feb 14, 2024, the NADAC for ESCITALOPRAM 5 MG TABLET has ranged from a low of $0.0328 (Nov 20, 2024) to a high of $0.0501 (Apr 10, 2024), with a median of $0.0423 per EA.
Are there cheaper alternatives to ESCITALOPRAM 5 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ESCITALOPRAM 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ESCITALOPRAM 5 MG TABLET?
ESCITALOPRAM 5 MG TABLET (NDC 68001059100) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.